Benzodiazepines linked to risk of Alzheimer’s disease Although data showed benzodiazepine and Z drug use was linked to only a 6% increase in the odds of developing Alzheimer’s disease, researchers say their prescribing should be avoided if possible.…
‘Real-life’ gait analysis can guide MS treatment, researchers say Use of a body-worn sensor to track movements could help grade a person’s severity of multiple sclerosis, guiding treatment, research has shown.…
First treatment to slow disability progression in secondary progressive MS, researchers say A sphingosine-1-phosphate receptor modulator has been shown to slow disability progression in people with secondary progressive multiple sclerosis for the first time…
EMA revises guidance for medicines development in Alzheimer’s disease European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a revised guideline on clinical studies for medicines that target Alzheimer’s disease.…
Working to reverse the cognitive decline of dementia The end of Alzheimer’s: the first programme to prevent and reverse the cognitive decline of dementia, by Dale E Bredesen…
Promising Alzheimer’s drug disappoints in phase III trials Drug that appeared a promising candidate for treating Alzheimer’s has failed to show benefits in phase III trials…
Turning off the Huntington’s gene Initial safety and tolerability trials of breakthrough Huntington’s therapy are a success, but we must await judgment on clinical efficacy.…
Slowing disease progress primary concern for MS patients, survey finds Efficacy is the greatest concern for patients with multiple sclerosis when considering treatment options, according to an international survey of more than 1000 people…
Antihistamine shows potential to repair neuron damage in multiple sclerosis Research shows an over-the-counter antihistamine could act as a remyelinating agent in multiple sclerosis…
Antidepressant nortriptyline could slow Parkinson’s pathology The drug could be used as a multi-functional compound to treat comorbid depression in Parkinson’s disease and also slow down the progress of the disease, researchers say.…
